Happy Wednesday and welcome to the Morning Six-Pack, where we're always trying to beat analyst estimates and surprise to the upside.
What, us worry? McDonald's says it doesn't care about its competitors in the burgeoning fast-food breakfast wars, insisting that it remains the unbridled leader. (Quartz)
What's French for "junk"? Apparently it doesn't matter, with the largest high-yield bond sale in history about to commence. (Forbes)
Can Facebook stop the bleeding? That will be the big question when the social network, whose stock has surged then plunged then popped this year, reports its quarterly earnings after the bell Wednesday. (InvestorPlace)
Can Amazon stop the bleeding? That will be the big question when the online retailer, whose stock has plunged, popped, plunged again and popped again this year, reports its quarterly earnings after the bell Wednesday. (Zacks)
Life isn't getting any easier for high-profile electric car maker Tesla, whose next challenge will be coming from hydrogen-powered vehicles. (Daily Finance)
And finally ... Bill Ackman acknowledges that his bid with Valeant to take over Allergan came from inside information, but was still within the boundaries of the law. CNBC's Matthew J. Belvedere and Maneet Ahuja help sort it out.
—By CNBC's Jeff Cox.
